Clinic
STC Opco LLC
STC Opco LLC was paid $69.20M by Medicaid between Dec 2019 and Dec 2024, across 267 billing codes. Its largest line is 99283, emergency room visit (moderate) — 26% of everything it billed.
33Billing provider infoSTC OPCO LLC
PHILADELPHIA, PA 19134
PHILADELPHIA, PA 19134
33aNPI1194368167assigned 10/23/2019
33bProvider typeSleep Disorder Diagnostic Clinic/Center
28Total paid$69.20M
24GClaims455,601
24DCodes billed267
24AFirst – last monthDec 2019 – Dec 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RAYME, BRIAN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 617 | $25K | |
| 2020 | 53,936 | $4.69M | |
| 2021 | 132,965 | $17.07M | |
| 2022 | 78,499 | $12.31M | |
| 2023 | 80,761 | $14.65M | |
| 2024incomplete | 108,823 | $20.46M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 26% | 74,654 | 72,253 | $17.69M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 22% | 60,683 | 58,989 | $15.05M |
| G0378 | Hospital observation service, per hour | 20% | 7,063 | 6,212 | $13.63M |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 4.6% | 1,097 | 1,084 | $3.19M |
| 41899 | Unlisted procedure, dentoalveolar structures | 2.8% | 1,035 | 1,015 | $1.94M |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 2.8% | 827 | 820 | $1.91M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.0% | 15,083 | 14,026 | $1.39M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.8% | 2,900 | 2,825 | $1.21M |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 1.4% | 15,647 | 4,843 | $941K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.2% | 7,825 | 2,902 | $853K |
| D7140 | Extraction, erupted tooth or exposed root | 1.1% | 668 | 466 | $790K |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 1,372 | 744 | $660K |
255 more codes
| 93325 | <1% | 3,482 | $608K | |
| 94010 | <1% | 6,159 | $555K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 5,826 | $545K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | <1% | 788 | $537K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 843 | $505K |
| 99218 | <1% | 271 | $438K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 4,724 | $403K |
| D1120 | Dental cleaning, child | <1% | 824 | $380K |
| 99285 | Emergency room visit (most serious) | <1% | 2,024 | $353K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 212 | $310K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 10,824 | $265K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 465 | $238K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 4,407 | $217K |
| D2934 | <1% | 126 | $209K | |
| 95782 | <1% | 229 | $207K | |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 166 | $194K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,959 | $166K |
| 92567 | <1% | 7,926 | $158K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 15,734 | $157K |
| 92579 | <1% | 2,252 | $142K | |
| 72082 | <1% | 1,705 | $117K | |
| 93304 | <1% | 537 | $116K | |
| 76770 | <1% | 1,532 | $115K | |
| D1351 | Sealant - per tooth | <1% | 428 | $110K |
| 80053 | Comprehensive metabolic panel | <1% | 5,201 | $105K |
| 97161 | <1% | 608 | $103K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,142 | $103K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 961 | $99K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 438 | $97K |
| OP370 | <1% | 3,059 | $93K | |
| 95812 | <1% | 527 | $84K | |
| 67311 | <1% | 30 | $76K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,335 | $72K |
| 93308 | <1% | 369 | $68K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 214 | $66K |
| 92552 | <1% | 2,227 | $64K | |
| 87631 | <1% | 958 | $58K | |
| 93320 | <1% | 390 | $57K | |
| 54161 | <1% | 27 | $55K | |
| 92587 | <1% | 943 | $54K | |
| OP710 | <1% | 2,953 | $51K | |
| 97165 | <1% | 240 | $48K | |
| 82248 | <1% | 2,662 | $47K | |
| 76825 | <1% | 306 | $46K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 350 | $43K |
| 93321 | <1% | 1,136 | $41K | |
| 92555 | <1% | 2,529 | $41K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 921 | $41K |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | <1% | 111 | $40K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 95 | $40K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 67 | $37K |
| 83615 | <1% | 2,801 | $35K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 40 | $33K |
| 95816 | <1% | 171 | $32K | |
| 74019 | <1% | 1,259 | $32K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,093 | $31K |
| 36430 | <1% | 393 | $31K | |
| 82977 | <1% | 2,167 | $31K | |
| 84100 | <1% | 3,433 | $30K | |
| 84550 | <1% | 2,467 | $30K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 80 | $29K |
| 83735 | <1% | 3,329 | $29K | |
| 92588 | <1% | 210 | $26K | |
| 76820 | <1% | 470 | $26K | |
| 92550 | <1% | 490 | $24K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,426 | $24K |
| 73562 | <1% | 823 | $21K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 666 | $21K |
| 92526 | <1% | 225 | $20K | |
| 92523 | <1% | 108 | $20K | |
| 73610 | <1% | 884 | $20K | |
| 92556 | <1% | 763 | $20K | |
| OP272 | <1% | 2,063 | $19K | |
| 93975 | <1% | 172 | $19K | |
| 76827 | <1% | 306 | $18K | |
| 85045 | <1% | 3,820 | $18K | |
| D1206 | Topical application of fluoride varnish | <1% | 674 | $18K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 203 | $17K |
| 73630 | <1% | 775 | $16K | |
| 93225 | <1% | 276 | $15K | |
| 29075 | <1% | 94 | $15K | |
| 77072 | <1% | 300 | $14K | |
| 70360 | <1% | 525 | $13K | |
| 73130 | <1% | 679 | $13K | |
| 76885 | <1% | 128 | $12K | |
| 73090 | <1% | 679 | $12K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 146 | $12K |
| 73590 | <1% | 506 | $12K | |
| 76536 | <1% | 175 | $11K | |
| 96415 | <1% | 181 | $11K | |
| 72170 | <1% | 418 | $11K | |
| 73080 | <1% | 468 | $10K | |
| 96409 | <1% | 104 | $10K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 315 | $9K |
| 70486 | <1% | 105 | $9K | |
| 86900 | <1% | 603 | $9K | |
| 73521 | <1% | 158 | $9K | |
| 92553 | <1% | 233 | $8K | |
| 74018 | <1% | 476 | $8K | |
| 29125 | <1% | 71 | $8K | |
| 29425 | <1% | 41 | $8K | |
| 73100 | <1% | 227 | $8K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 745 | $8K |
| 12011 | <1% | 259 | $8K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 313 | $7K |
| 77074 | <1% | 95 | $7K | |
| 97162 | <1% | 75 | $7K | |
| 87081 | <1% | 1,357 | $7K | |
| 87077 | <1% | 584 | $6K | |
| 73110 | <1% | 482 | $6K | |
| 29065 | <1% | 46 | $6K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 126 | $6K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,284 | $6K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 973 | $6K |
| 86920 | <1% | 61 | $6K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 112 | $6K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 24 | $6K |
| 92557 | <1% | 125 | $6K | |
| 73140 | <1% | 193 | $5K | |
| 77073 | <1% | 139 | $4K | |
| 94664 | <1% | 695 | $4K | |
| 77075 | <1% | 70 | $4K | |
| 0001A | <1% | 654 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 585 | $4K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 2,932 | $4K |
| 81001 | <1% | 2,567 | $4K | |
| 76870 | <1% | 85 | $3K | |
| OP250 | <1% | 9,910 | $3K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 46 | $3K |
| 93976 | <1% | 99 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 313 | $3K |
| D2933 | <1% | 15 | $3K | |
| 76981 | <1% | 36 | $3K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 663 | $3K |
| J3490 | Unclassified drugs | <1% | 7,849 | $3K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 436 | $3K |
| 0002A | <1% | 232 | $3K | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 354 | $2K |
| 92582 | <1% | 44 | $2K | |
| 81002 | <1% | 1,097 | $2K | |
| 81025 | <1% | 2,166 | $2K | |
| 73552 | <1% | 121 | $2K | |
| 86850 | <1% | 254 | $2K | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 453 | $2K |
| 82962 | <1% | 634 | $2K | |
| 94644 | <1% | 1,174 | $2K | |
| 73030 | <1% | 150 | $2K | |
| 16020 | <1% | 14 | $2K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 5,354 | $2K |
| 85027 | <1% | 376 | $2K | |
| 73060 | <1% | 99 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 6,899 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 13,611 | $2K |
| 87070 | <1% | 342 | $2K | |
| 86901 | <1% | 257 | $1K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 8,964 | $1K |
| 73564 | <1% | 15 | $1K | |
| 73560 | <1% | 54 | $1K | |
| 73000 | <1% | 71 | $1K | |
| 97166 | <1% | 13 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 8,917 | $1K |
| 24640 | <1% | 44 | $1K | |
| J2704 | Injection, propofol, 10 mg | <1% | 6,953 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 403 | $1K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 289 | $964.01 |
| 87186 | <1% | 445 | $932.07 | |
| 12001 | <1% | 109 | $889.64 | |
| 92610 | <1% | 13 | $853.72 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 28 | $837.60 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 403 | $825.99 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 666 | $814.00 |
| 87507 | <1% | 14 | $730.34 | |
| 87040 | <1% | 289 | $667.68 | |
| A9150 | Non-prescription drugs | <1% | 268 | $648.61 |
| 87205 | <1% | 330 | $519.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,211 | $512.92 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 208 | $504.80 |
| 76000 | <1% | 108 | $498.96 | |
| 88304 | <1% | 716 | $495.68 | |
| J3535 | Drug administered through a metered dose inhaler | <1% | 179 | $490.63 |
| 87088 | <1% | 484 | $482.16 | |
| 87486 | <1% | 309 | $474.33 | |
| 71045 | Radiologic examination, chest; single view | <1% | 102 | $457.56 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,521 | $428.09 |
| 83690 | <1% | 435 | $404.09 | |
| 85007 | <1% | 207 | $360.71 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 33 | $353.09 |
| 86140 | <1% | 647 | $350.99 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 176 | $343.55 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 309 | $328.78 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 194 | $236.13 |
| OP270 | <1% | 116 | $225.74 | |
| 82150 | <1% | 68 | $214.29 | |
| 94645 | <1% | 233 | $210.93 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,386 | $209.45 |
| 80143 | <1% | 12 | $206.32 | |
| 88312 | <1% | 133 | $206.28 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,692 | $195.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,188 | $187.29 |
| 92551 | <1% | 13 | $182.39 | |
| 84484 | <1% | 79 | $165.24 | |
| 76377 | <1% | 35 | $163.44 | |
| 90715 | <1% | 30 | $162.26 | |
| 72040 | <1% | 13 | $161.22 | |
| 85651 | <1% | 342 | $156.12 | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | <1% | 1,341 | $147.37 |
| 90686 | <1% | 44 | $146.63 | |
| 86701 | <1% | 149 | $146.05 | |
| 85730 | <1% | 148 | $139.78 | |
| 80305 | <1% | 267 | $138.23 | |
| 85610 | <1% | 161 | $132.59 | |
| G0008 | Administration of influenza virus vaccine | <1% | 41 | $107.79 |
| 87147 | <1% | 151 | $107.52 | |
| 84702 | <1% | 25 | $99.51 | |
| 96376 | <1% | 30 | $94.86 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 14 | $89.53 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,024 | $85.86 |
| 87400 | <1% | 22 | $84.97 | |
| 87581 | <1% | 308 | $82.23 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | <1% | 1,552 | $79.27 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 473 | $79.20 |
| 86403 | <1% | 33 | $76.03 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,139 | $74.75 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 30 | $64.98 |
| 84439 | <1% | 39 | $54.88 | |
| 82805 | <1% | 15 | $51.68 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 127 | $49.06 |
| OP259 | <1% | 122 | $37.09 | |
| 85018 | <1% | 19 | $33.62 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 1,562 | $32.75 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 283 | $31.50 |
| 86592 | <1% | 26 | $23.96 | |
| 98960 | <1% | 39 | $22.08 | |
| 85652 | <1% | 94 | $16.46 | |
| 87045 | <1% | 12 | $16.08 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 33 | $11.70 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 39 | $9.57 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 47 | $8.28 |
| 36415 | Collection of venous blood by venipuncture | <1% | 192 | $7.29 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 14 | $6.40 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 125 | $2.68 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 536 | $0.04 |
| 84145 | 0% | 13 | $0.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 44 | $0.00 |
| A6250 | Skin sealants, protectants, moisturizers, ointments, any type, any size | 0% | 111 | $0.00 |
| L1830 | Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf | 0% | 31 | $0.00 |
| J7999 | Compounded drug, not otherwise classified | 0% | 308 | $0.00 |
| 00000 | 0% | 218 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 55 | $0.00 |
| 85008 | 0% | 81 | $0.00 | |
| 86780 | 0% | 38 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 17 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 22 | $0.00 |
| 99156 | 0% | 14 | $0.00 | |
| 12002 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRAYME, BRIAN (EVP & CFO)
| Provider | Location | Paid |
|---|---|---|
| Tower Health Urgent Care, LLC | Douglassville, PA | $11.77M |
| Pottstown Hospital, LLC | Pottstown, PA | $7.54M |
| Phoenixville Hospital, LLC | Phoenixville, PA | $4.61M |
| Pottstown Clinic Company LLC | Pottstown, PA | $2.96M |
| Tower Drexel Academic Medical Group LLC | Philadelphia, PA | $2.47M |
| STC Opco LLC | Philadelphia, PA | $2.06M |
| STC Pediatrics LLC | Philadelphia, PA | $2.06M |
| STC Pediatrics LLC | Philadelphia, PA | $1.73M |
| Phoenixville Clinic Company LLC | Phoenixville, PA | $1.68M |
| STC Pediatrics LLC | Philadelphia, PA | $1.48M |
| STC Pediatrics LLC | Philadelphia, PA | $1.31M |
| Tower Health Medical Group | Wyomissing, PA | $1.28M |
| STC Pediatrics LLC | Philadelphia, PA | $988K |
| Tower Health Medical Group | West Reading, PA | $850K |
| Tower Health Medical Group | West Reading, PA | $724K |
| Tower Health Medical Group | West Reading, PA | $720K |
| Tower Health Medical Group | Birdsboro, PA | $543K |
| STC Pediatrics LLC | Philadelphia, PA | $497K |
| STC Pediatrics LLC | Philadelphia, PA | $462K |
| STC Pediatrics LLC | Philadelphia, PA | $449K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.